We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Informatics Workstation Features CT Contrast Dose Management Systems

By HospiMedica International staff writers
Posted on 21 Jun 2012
A new workstation is an informatics-driven touch-screen hub that enables timesavings and improved patient care through a powerful range of computed tomography (CT) contrast dose-management applications and a new P3T 2.0 operating environment. More...


The new Certegra workstation, developed by Bayer Radiology & Interventional (Tarrytown, NY, USA), was presented at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM) 2012 June 7-12, 2012, in Orlando (FL, USA). Following the initial launch in the United States and Canada, the workstation will be rolled out in phases in markets worldwide.

The Workstation serves as a single interface for radiology technologists, enabling them to provide improved patient care from study set-up and preparation to administration of the patient's study. It will be the cornerstone of Bayer's industry-first contrast dose management solution and informatics platform. In establishing and uploading the patient’s contrast-injection record, the workstation imports patient data directly from the Modality Work List--reducing manual entry errors to the patient record.

“Today’s technology-driven CT suite demands timely access to reliable contrast-dose records throughout the chain of care,” said Anthony Cinalli, vice president of the informatics business at Bayer Radiology & Interventional. “Enabling a single workflow-centralized interface, the workstation allows for fewer clicks, less manual entry, and greater control over the quality and consistency of patient care.”

Interfacing with Medrad Stellant CT injection systems, the Workstation's comprehensive suite of software options provides physicians and healthcare professionals instant access to real-time actionable CT contrast data captured at the point of care--enabling benefits including (1) reducing subdiagnostic studies, unnecessary rescans and associated radiation exposure (P3T 2.0 for personalized CT abdominal, cardiac and pulmonary angiography studies); (2) enabling more complete diagnostic decisions (picture archiving and communication system [PACS] outbound interface); (3) Speeding-up radiology report turnaround time and create greater study-volume bandwidth (radiology information system [RIS] and SR outbound interfaces); and (4) improving department performance by trending, reporting and analyzing actionable data with pinpoint accuracy (Informatics Starter Package, and the data analysis and reporting tool).

Related Links:
Bayer Radiology & Interventional



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.